Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02917720
Title 2nd or 3rd TKI-stop After 2 Years Nilotinib Pre-treatment in CML-patients (NAUT)
Acronym NAUT
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors European LeukemiaNet
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD | DEU

Facility Status City State Zip Country Details
Universitätsklinikum Freiburg Freiburg Baden-Württemberg 79108 Germany Details
Universitätsmedizin Mannheim Mannheim Baden-Württemberg 68167 Germany Details
Klinikum rechts der Isar München Bayern 81675 Germany Details
Medizinische Hochschule Hannover Hannover NRW 30625 Germany Details
Universitätsklinikum der RWTH Aachen 52074 Germany Details
Klinikum Bayreuth Bayreuth 95445 Germany Details
Klinikum Chemnitz Chemnitz 09113 Germany Details
Onkologische Schwerpunktpraxis Esslingen 73728 Germany Details
Universitätsklinikum Halle (Saale) Halle (Saale) Germany Details
Schwerpunktpraxis Onkologie Heilbronn 74072 Germany Details
Klinikum der Philipps-Universität Marburg 35033 Germany Details
Kliniken Ostalb, Stauferklinikum Schwäbisch Gmünd Mutlangen 73557 Germany Details
Universitätsklinikum Rostock Rostock 18057 Germany Details
Schwarzwald-Baar Klinikum Villingen-Schwenningen 78052 Germany Details
Amsterdam UMC, locatie VUmc Amsterdam 1081 HV Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field